News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
765,581 Results
Type
Article (77200)
Company Profile (457)
Press Release (687924)
Section
Business (205183)
Career Advice (3551)
Deals (37026)
Drug Delivery (122)
Drug Development (87770)
Employer Resources (179)
FDA (16975)
Job Trends (16011)
News (357505)
Policy (35199)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (9)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (10)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (11)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (9)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (12)
2024 Pharm Country Digital (10)
2024 Pharm Country Standard (7)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2967)
Academic (2)
Accelerated approval (3)
Adcomms (29)
Allergies (83)
Alliances (52265)
ALS (83)
Alzheimer's disease (1435)
Antibody-drug conjugate (ADC) (129)
Approvals (16929)
Artificial intelligence (249)
Autoimmune disease (13)
Automation (14)
Bankruptcy (351)
Best Places to Work (12342)
BIOSECURE Act (21)
Biosimilars (101)
Biotechnology (332)
Bladder cancer (57)
Brain cancer (28)
Breast cancer (252)
Cancer (1934)
Cardiovascular disease (152)
Career advice (3007)
Career pathing (32)
CAR-T (150)
Cell therapy (427)
Cervical cancer (15)
Clinical research (70213)
Collaboration (760)
Compensation (399)
Complete response letters (28)
COVID-19 (2810)
CRISPR (38)
C-suite (196)
Cystic fibrosis (104)
Data (1757)
Decentralized trials (2)
Denatured (36)
Depression (45)
Diabetes (241)
Diagnostics (6730)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (115)
Drug pricing (119)
Drug shortages (32)
Duchenne muscular dystrophy (70)
Earnings (76826)
Editorial (34)
Employer branding (23)
Employer resources (156)
Events (120844)
Executive appointments (625)
FDA (17997)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (682)
Gene editing (98)
Generative AI (27)
Gene therapy (300)
GLP-1 (766)
Government (4954)
Grass and pollen (4)
Guidances (46)
Healthcare (20450)
Huntington's disease (23)
IgA nephropathy (22)
Immunology and inflammation (108)
Indications (24)
Infectious disease (2937)
Inflammatory bowel disease (139)
Inflation Reduction Act (11)
Influenza (47)
Intellectual property (74)
Interviews (687)
IPO (17157)
IRA (50)
Job creations (4154)
Job search strategy (2474)
Kidney cancer (10)
Labor market (25)
Layoffs (517)
Leadership (19)
Legal (8228)
Liver cancer (74)
Lung cancer (281)
Lymphoma (124)
Machine learning (2)
Management (61)
Manufacturing (271)
MASH (62)
Medical device (14003)
Medtech (14008)
Mergers & acquisitions (20308)
Metabolic disorders (650)
Multiple sclerosis (64)
NASH (22)
Neurodegenerative disease (86)
Neuropsychiatric disorders (28)
Neuroscience (1909)
NextGen: Class of 2025 (7337)
Non-profit (5014)
Northern California (2255)
Now hiring (31)
Obesity (355)
Opinion (263)
Ovarian cancer (64)
Pain (81)
Pancreatic cancer (72)
Parkinson's disease (125)
Partnered (18)
Patents (188)
Patient recruitment (83)
Peanut (50)
People (62213)
Pharmaceutical (91)
Pharmacy benefit managers (20)
Phase I (21866)
Phase II (30676)
Phase III (22884)
Pipeline (840)
Podcasts (103)
Policy (125)
Postmarket research (3164)
Preclinical (9742)
Press Release (71)
Prostate cancer (89)
Psychedelics (38)
Radiopharmaceuticals (264)
Rare diseases (376)
Real estate (6668)
Recruiting (71)
Regulatory (23990)
Reports (38)
Research institute (2638)
Resumes & cover letters (556)
Rett syndrome (2)
RNA editing (1)
RSV (43)
Schizophrenia (68)
Series A (125)
Series B (73)
Service/supplier (17)
Sickle cell disease (55)
Southern California (1941)
Special edition (17)
Sponsored (33)
Startups (3837)
State (2)
Stomach cancer (14)
Supply chain (60)
The Weekly (66)
United States (20399)
Vaccines (716)
Venture capitalists (35)
Webinars (13)
Weight loss (263)
Women's health (35)
Worklife (16)
Date
Today (182)
Last 7 days (819)
Last 30 days (3179)
Last 365 days (36287)
2025 (6145)
2024 (37177)
2023 (41899)
2022 (53176)
2021 (58010)
2020 (56739)
2019 (50261)
2018 (38300)
2017 (35485)
2016 (35715)
2015 (41725)
2014 (35281)
2013 (31421)
2012 (32880)
2011 (33118)
2010 (32260)
Location
Africa (1093)
Alabama (55)
Alaska (7)
Arizona (208)
Arkansas (13)
Asia (45161)
Australia (8046)
California (5208)
Canada (1779)
China (439)
Colorado (236)
Connecticut (260)
Delaware (114)
Europe (104683)
Florida (758)
Georgia (179)
Idaho (63)
Illinois (534)
India (21)
Indiana (287)
Iowa (8)
Japan (129)
Kansas (103)
Kentucky (25)
Louisiana (8)
Maine (67)
Maryland (816)
Massachusetts (4078)
Michigan (215)
Minnesota (365)
Mississippi (2)
Missouri (77)
Montana (31)
Nebraska (24)
Nevada (55)
New Hampshire (67)
New Jersey (1481)
New Mexico (30)
New York (1493)
North Carolina (975)
North Dakota (8)
Northern California (2255)
Ohio (188)
Oklahoma (14)
Oregon (37)
Pennsylvania (1161)
Puerto Rico (7)
Rhode Island (23)
South America (1451)
South Carolina (14)
South Dakota (1)
Southern California (1941)
Tennessee (83)
Texas (765)
Utah (163)
Virginia (124)
Washington D.C. (61)
Washington State (507)
West Virginia (3)
Wisconsin (53)
765,581 Results for "the institute of cancer research icr".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
March 4, 2025
·
6 min read
Press Releases
The Stephenson Global Pancreatic Cancer Research Institute Launches First-of-Its-Kind Global Scientific Awards to Advance Breakthrough Discovery in Pancreatic Cancer
February 14, 2025
·
6 min read
Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA therapeutics
Providence Therapeutic Holdings Inc. and the Ontario Institute for Cancer Research, Ontario’s largest publicly funded cancer research institute delivering real-world solutions to people affected by cancer, announced the signing of a collaboration agreement for mRNA drug discovery and development.
May 23, 2024
·
3 min read
Press Releases
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -
January 17, 2025
·
8 min read
Press Releases
Lung Cancer Research Foundation Announces Research Collaboration with Israel Cancer Research Fund
February 19, 2025
·
5 min read
Press Releases
CytoMed Therapeutics signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers in a proposed Phase 2 clinical trial in India
January 6, 2025
·
6 min read
Pharm Country
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, launched a pilot program and enrolled the first patients on the Veris Cancer Care Platform™ pursuant to a recently-executed memorandum of understanding.
June 13, 2024
·
5 min read
Press Releases
Small Cell Lung Cancer Market Size to Reach USD 23.0 Billion by 2035, Impelled by Improved Early Diagnosis & Biomarker Research
Small Cell Lung Cancer Market Outlook 2025-2035:
February 17, 2025
·
9 min read
Press Releases
Florida Cancer Specialists & Research Institute President Invited to Speak at White House Event Celebrating Cancer Moonshot and Nationwide Efforts to End Cancer
January 7, 2025
·
4 min read
Press Releases
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
December 18, 2024
·
7 min read
1 of 76,559
Next
